ZNF582
gene geneOn this page
Also known as FLJ30927
Summary
ZNF582 (zinc finger protein 582, HGNC:26421) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 582 (Q96NG8). May be involved in transcriptional regulation.
The protein encoded by this gene is a zing finger protein and putative transcription factor that is highly methylated in cervical cancers. Two transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 147948 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 31 total
- MANE Select transcript:
NM_001320371
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26421 |
| Approved symbol | ZNF582 |
| Name | zinc finger protein 582 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ30927 |
| Ensembl gene | ENSG00000018869 |
| Ensembl biotype | protein_coding |
| OMIM | 615600 |
| Entrez | 147948 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 5 protein_coding, 2 non_stop_decay
ENST00000301310, ENST00000586929, ENST00000587778, ENST00000589143, ENST00000589895, ENST00000593145, ENST00000932869
RefSeq mRNA: 2 — MANE Select: NM_001320371
NM_001320371, NM_144690
CCDS: CCDS33121
Canonical transcript exons
ENST00000586929 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001708509 | 56391744 | 56391832 |
| ENSE00002480943 | 56390375 | 56390501 |
| ENSE00002493313 | 56390001 | 56390096 |
| ENSE00002780726 | 56382751 | 56385184 |
| ENSE00002865128 | 56393220 | 56393534 |
Expression profiles
Bgee: expression breadth ubiquitous, 181 present calls, max score 88.07.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.8214 / max 54.2742, expressed in 1290 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182879 | 1.8494 | 1037 |
| 182880 | 0.9721 | 548 |
Top tissues by expression
236 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tibialis anterior | UBERON:0001385 | 88.07 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.74 | gold quality |
| ileal mucosa | UBERON:0000331 | 85.68 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.96 | gold quality |
| upper arm skin | UBERON:0004263 | 80.45 | gold quality |
| pancreatic ductal cell | CL:0002079 | 79.92 | silver quality |
| apex of heart | UBERON:0002098 | 79.00 | gold quality |
| right adrenal gland | UBERON:0001233 | 78.06 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 77.75 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 77.63 | gold quality |
| cerebellar cortex | UBERON:0002129 | 77.59 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 77.58 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 77.52 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 77.43 | gold quality |
| adenohypophysis | UBERON:0002196 | 77.26 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 77.20 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 77.09 | gold quality |
| deltoid | UBERON:0001476 | 76.91 | silver quality |
| left adrenal gland | UBERON:0001234 | 76.78 | gold quality |
| spinal cord | UBERON:0002240 | 76.71 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 76.68 | gold quality |
| pituitary gland | UBERON:0000007 | 76.64 | gold quality |
| islet of Langerhans | UBERON:0000006 | 76.61 | gold quality |
| thyroid gland | UBERON:0002046 | 76.55 | gold quality |
| cerebellum | UBERON:0002037 | 76.46 | gold quality |
| putamen | UBERON:0001874 | 76.43 | gold quality |
| nucleus accumbens | UBERON:0001882 | 76.20 | gold quality |
| adrenal cortex | UBERON:0001235 | 76.13 | gold quality |
| oocyte | CL:0000023 | 75.96 | gold quality |
| caudate nucleus | UBERON:0001873 | 75.87 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.94 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1983.1 | ZNF582 | More than 3 adjacent zinc fingers |
| MA1983.2 | ZNF582 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:31162603
miRNA regulators (miRDB)
72 targeting ZNF582, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-613 | 99.91 | 71.50 | 1710 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-4671-3P | 99.88 | 72.46 | 1045 |
| HSA-MIR-605-3P | 99.88 | 69.22 | 1833 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-6844 | 99.82 | 70.69 | 2423 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
| HSA-MIR-548F-3P | 99.82 | 70.59 | 3540 |
| HSA-MIR-4760-5P | 99.80 | 69.88 | 1619 |
| HSA-MIR-1299 | 99.77 | 71.24 | 2389 |
| HSA-MIR-548A-3P | 99.76 | 70.58 | 3524 |
| HSA-MIR-4677-5P | 99.70 | 70.09 | 1940 |
Literature-anchored findings (GeneRIF, showing 16)
- ZNF582 is frequently methylated in cervical intraepithelial neoplasia 3 and worse lesions (PMID:22815913)
- Methylation levels of ZNF582 in uterine cervix adenocarcinomas is significantly higher than those in normal cervical tissues. (PMID:24407576)
- This is the first study to show that ZNF582 methylation analysis of cervical swabs may be a promising choice in the positive triage of cytological diagnoses of low-grade squamous intraepithelial lesions (PMID:25134998)
- Results show that promoter hypermethylation of ADCY8, CDH8, and ZNF582 are correlated with high-grade squamous intraepithelial lesion. (PMID:27651839)
- conclude that hypermethylated ZNF582 and PAX1 are effective biomarkers for the detection of oral dysplasia and oral cancer and for the prediction of oral cancer recurrence (PMID:27865370)
- DNA methylation status of ZNF582 showed a relatively good sensitivity and specificity for the detection of ESOPHAGEAL SQUAMOUS CELL CARCINOMA. (PMID:28241446)
- Hypermethylated ZNF582 and PAX1 genes in oral epithelial cells collected by mouth rinse are effective biomarkers for the detection of oral dysplasia and oral cancer. (PMID:28960639)
- Hypermethylated ZNF582 and PAX1 genes in the oral scrapings collected from adjacent normal oral mucosal sites rather than cancer sites are associated with aggressive progression and poor prognosis of OSCC (PMID:29224816)
- ZNF582 methylation has a prospect to be an auxiliary biomarker for cervical cancer (Meta-Analysis) (PMID:30732145)
- The methylation levels ofPAX1, SOX1 and ZNF582 genes were all higher in cancer tissues. (PMID:31629253)
- Hypermethylated PAX1 and ZNF582 genes in the tissue sample are associated with aggressive progression of oral squamous cell carcinoma. (PMID:32428271)
- The application value of PAX1 and ZNF582 gene methylation in high grade intraepithelial lesion and cervical cancer. (PMID:32514824)
- ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin-3 and NRXN3. (PMID:33038291)
- ZNF582 promoter methylation predicts cervical cancer radiosensitivity and ZNF582 protein overexpression reduces radiosensitivity by cell cycle arrest in S phase. (PMID:35642528)
- ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation. (PMID:36966163)
- Relationship between p16/ki67 immunoscores and PAX1/ZNF582 methylation status in precancerous and cancerous cervical lesions in high-risk HPV-positive women. (PMID:39304838)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp582 | ENSMUSG00000109398 |
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 582 — Q96NG8 (reviewed: Q96NG8)
All UniProt accessions (5): A0A075B771, A0A075B772, Q96NG8, K7EKI7, K7ESE7
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (2): NP_001307300, NP_653291 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (21 total): zinc finger region 10, sequence conflict 6, sequence variant 3, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96NG8-F1 | 63.04 | 0.05 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 44 (showing top):
TCF11_01, NOUZOVA_METHYLATED_IN_APL, STAT1_02, YKACATTT_UNKNOWN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, STAT1_03, FIGUEROA_AML_METHYLATION_CLUSTER_1_UP, FIGUEROA_AML_METHYLATION_CLUSTER_2_UP, FIGUEROA_AML_METHYLATION_CLUSTER_3_UP, FIGUEROA_AML_METHYLATION_CLUSTER_4_UP, FIGUEROA_AML_METHYLATION_CLUSTER_6_UP, FIGUEROA_AML_METHYLATION_CLUSTER_7_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, IRF5_TARGET_GENES, SUPT16H_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
348 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF582 | PAX1 | P15863 | 776 |
| ZNF582 | TAFA4 | Q96LR4 | 579 |
| ZNF582 | SOX1 | O00570 | 577 |
| ZNF582 | WDR17 | Q8IZU2 | 542 |
| ZNF582 | PTPRR | Q15256 | 479 |
| ZNF582 | RUBCNL | Q9H714 | 479 |
| ZNF582 | LHX8 | Q68G74 | 474 |
| ZNF582 | EPB41L3 | Q9Y2J2 | 474 |
| ZNF582 | ST6GALNAC5 | Q9BVH7 | 418 |
| ZNF582 | POU4F3 | Q15319 | 403 |
| ZNF582 | LMX1A | Q8TE12 | 382 |
| ZNF582 | PCDHA13 | Q9Y5I0 | 373 |
| ZNF582 | CDH8 | P55286 | 371 |
| ZNF582 | PCDHA4 | Q9UN74 | 364 |
| ZNF582 | NKX6-1 | P78426 | 353 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF582 | NECTIN4 | psi-mi:“MI:0915”(physical association) | 0.590 |
| ZNF582 | ECE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (6): PVRL4 (Affinity Capture-MS), PVRL4 (Affinity Capture-MS), ZNF582 (Proximity Label-MS), ZNF582 (Affinity Capture-MS), PVRL4 (Affinity Capture-MS), ZNF582 (Affinity Capture-MS)
ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
31 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 23 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
566 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:56391742:A:AC | donor_gain | 1.0000 |
| 19:56391743:C:CC | donor_gain | 1.0000 |
| 19:56391833:C:CC | acceptor_gain | 1.0000 |
| 19:56385185:C:CC | acceptor_gain | 0.9900 |
| 19:56389757:T:A | donor_gain | 0.9900 |
| 19:56389997:TCACC:T | donor_loss | 0.9900 |
| 19:56389998:CACCT:C | donor_loss | 0.9900 |
| 19:56389999:ACCT:A | donor_loss | 0.9900 |
| 19:56390000:C:A | donor_loss | 0.9900 |
| 19:56390499:CCC:C | acceptor_gain | 0.9900 |
| 19:56390500:CCC:C | acceptor_gain | 0.9900 |
| 19:56391743:CA:C | donor_gain | 0.9900 |
| 19:56391784:T:TA | donor_gain | 0.9900 |
| 19:56391828:TAGAG:T | acceptor_gain | 0.9900 |
| 19:56391830:GAG:G | acceptor_gain | 0.9900 |
| 19:56391830:GAGC:G | acceptor_loss | 0.9900 |
| 19:56391832:GC:G | acceptor_loss | 0.9900 |
| 19:56391833:C:CA | acceptor_loss | 0.9900 |
| 19:56382920:T:C | acceptor_gain | 0.9800 |
| 19:56382924:A:C | acceptor_gain | 0.9800 |
| 19:56385180:CAATA:C | acceptor_gain | 0.9800 |
| 19:56389784:A:AC | donor_gain | 0.9800 |
| 19:56389995:ACTC:A | donor_loss | 0.9800 |
| 19:56390094:GACCT:G | acceptor_loss | 0.9800 |
| 19:56390097:C:CA | acceptor_loss | 0.9800 |
| 19:56390368:ACCTT:A | donor_loss | 0.9800 |
| 19:56390369:CCTTA:C | donor_loss | 0.9800 |
| 19:56390370:CTTA:C | donor_loss | 0.9800 |
| 19:56390371:TTA:T | donor_loss | 0.9800 |
| 19:56390372:TA:T | donor_loss | 0.9800 |
AlphaMissense
3458 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:56384541:G:C | F292L | 0.997 |
| 19:56384541:G:T | F292L | 0.997 |
| 19:56384543:A:G | F292L | 0.997 |
| 19:56384625:A:C | F264L | 0.997 |
| 19:56384625:A:T | F264L | 0.997 |
| 19:56384627:A:G | F264L | 0.997 |
| 19:56384205:G:C | F404L | 0.995 |
| 19:56384205:G:T | F404L | 0.995 |
| 19:56384207:A:G | F404L | 0.995 |
| 19:56384289:A:C | F376L | 0.995 |
| 19:56384289:A:T | F376L | 0.995 |
| 19:56384291:A:G | F376L | 0.995 |
| 19:56384709:G:C | F236L | 0.995 |
| 19:56384709:G:T | F236L | 0.995 |
| 19:56384711:A:G | F236L | 0.995 |
| 19:56384121:A:C | F432L | 0.994 |
| 19:56384121:A:T | F432L | 0.994 |
| 19:56384123:A:G | F432L | 0.994 |
| 19:56384373:A:C | F348L | 0.994 |
| 19:56384373:A:T | F348L | 0.994 |
| 19:56384375:A:G | F348L | 0.994 |
| 19:56384536:C:G | R294P | 0.994 |
| 19:56384457:A:C | F320L | 0.993 |
| 19:56384457:A:T | F320L | 0.993 |
| 19:56384459:A:G | F320L | 0.993 |
| 19:56384593:C:G | R275P | 0.993 |
| 19:56384272:A:G | L382P | 0.992 |
| 19:56384524:A:G | L298P | 0.991 |
| 19:56384188:A:G | L410P | 0.989 |
| 19:56384260:T:G | Q386P | 0.987 |
dbSNP variants (sampled 300 via entrez): RS1000186745 (19:56384447 A>G), RS1000225683 (19:56393738 C>A,G,T), RS1000273150 (19:56386851 A>G), RS1000411706 (19:56391685 A>T), RS1001053163 (19:56388958 A>G), RS1001368561 (19:56385171 T>A,C), RS1002334362 (19:56395154 A>G), RS1002378318 (19:56383578 T>C), RS1002686893 (19:56394864 T>G), RS1003058808 (19:56387034 T>C), RS1003288289 (19:56390210 G>A), RS1003426010 (19:56384343 CTGA>C), RS1004218120 (19:56383460 C>T), RS1004236074 (19:56387465 C>T), RS1004358072 (19:56389377 G>A)
Disease associations
OMIM: gene MIM:615600 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009269_20 | Dental caries (decayed and filled deciduous teeth) | 5.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| urushiol | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| hydroxyhydroquinone | increases expression | 1 |
| arsenite | decreases expression, increases methylation | 1 |
| ferrous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| bisphenol S | decreases methylation, affects cotreatment | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Irinotecan | affects cotreatment, increases response to substance | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Leucovorin | affects cotreatment, increases response to substance | 1 |
| Fluorouracil | increases response to substance, affects cotreatment | 1 |
| Valproic Acid | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.